Skip to main content Accessibility help

Oral administration of veratric acid, a constituent of vegetables and fruits, prevents cardiovascular remodelling in hypertensive rats: a functional evaluation

  • Murugesan Saravanakumar (a1) (a2), Boobalan Raja (a2), Jeganathan Manivannan (a2) (a3), Thangarasu Silambarasan (a2), Pichavaram Prahalathan (a2), Subramanian Kumar (a2) and Santosh Kumar Mishra (a4)...


In our previous studies, veratric acid (VA) shows beneficial effect on hypertension and its associated dyslipidaemia. In continuation, this study was designed to investigate the effect of VA, one of the major benzoic acid derivatives from vegetables and fruits, on cardiovascular remodelling in hypertensive rats, primarily assessed by functional studies using Langendorff isolated heart system and organ bath system. Hypertension was induced in male albino Wistar rats by oral administration of N ω -nitro-l-arginine methyl ester hydrochloride (l-NAME) (40 mg/kg body weight (b.w.)) in drinking water for 4 weeks. VA was orally administered at a dose of 40 mg/kg b.w. l-NAME-treated rats showed impaired cardiac ventricular and vascular function, evaluated by Langendorff isolated heart system and organ bath studies, respectively; a significant increase in the lipid peroxidation products such as thiobarbituric acid-reactive substances and lipid hydroperoxides in aorta; and a significant decrease in the activities of superoxide dismutase, catalase, glutathione peroxidase and levels of GSH, vitamin C and vitamin E in aorta. Fibrotic remodelling of the aorta and heart were assessed by Masson’s Trichrome staining and Van Gieson’s staining, respectively. In addition, l-NAME rats showed increased heart fibronectin expression assessed by immunohistochemical analysis. VA supplementation throughout the experimental period significantly normalised cardiovascular function, oxidative stress, antioxidant status and fibrotic remodelling of tissues. These results of the present study conclude that VA acts as a protective agent against hypertension-associated cardiovascular remodelling.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Oral administration of veratric acid, a constituent of vegetables and fruits, prevents cardiovascular remodelling in hypertensive rats: a functional evaluation
      Available formats

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Oral administration of veratric acid, a constituent of vegetables and fruits, prevents cardiovascular remodelling in hypertensive rats: a functional evaluation
      Available formats

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Oral administration of veratric acid, a constituent of vegetables and fruits, prevents cardiovascular remodelling in hypertensive rats: a functional evaluation
      Available formats


Corresponding author

* Corresponding author: Dr B. Raja, email


Hide All
1. Lopez, AD, Mathers, CD, Ezzati, M, et al. (2006) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367, 17471757.
2. Gu, D, Reynolds, K, Wu, X, et al. (2002) Prevalence, awareness, treatment, and control of hypertension in China. Hypertension 40, 920927.
3. Kearney, PM, Whelton, M, Reynolds, K, et al. (2005) Global burden of hypertension: analysis of worldwide data. Lancet 365, 217223.
4. Zhang, Y, Shao, L, Ma, A, et al. (2014) Telmisartan delays myocardial fibrosis in rats with hypertensive left ventricular hypertrophy by TGF-β1/Smad signal pathway. Hypertens Res 37, 4349.
5. Devereux, RB & Roman, MJ (1999) Left ventricular hypertrophy in hypertension: stimuli, patterns, and consequences. Hypertens Res 22, 19.
6. Katz, AM (1990) Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure. N Engl J Med 322, 100110.
7. Higashi, Y, Noma, K, Yoshizumi, M, et al. (2009) Endothelial function and oxidative stress in cardiovascular diseases. Circ J 73, 411418.
8. Sanada, S, Node, K, Minamino, T, et al. (2003) Long-acting Ca2+ blockers prevent myocardial remodeling induced by chronic NO inhibition in rats. Hypertension 41, 963967.
9. Rossi, MA & Colombini-Netto, M (2001) Chronic inhibition of NO synthesis per se promotes structural intimal remodeling of the rat aorta. J Hypertens 19, 15671579.
10. Ferreira, RN, Rocha, VN, da Silva Torres, T, et al. (2011) Beneficial effects of rosuvastatin on aortic adverse remodeling in nitric oxide-deficient rats. Exp Toxicol Pathol 63, 473478.
11. Kumar, S, Saravanakumar, M & Raja, B (2010) Efficacy of piperine, an alkaloidal constituent of pepper on nitric oxide, antioxidants and lipid peroxidation markers in l-NAME induced hypertensive rats. Int J Res Pharm Sci 1, 300307.
12. Retelny, VS, Neuendorf, A & Roth, JL (2008) Nutrition protocols for the prevention of cardiovascular disease. Nutr Clin Pract 23, 468476.
13. Kumar, S, Prahalathan, P & Raja, B (2011) Antihypertensive and antioxidant potential of vanillic acid, a phenolic compound in l-NAME-induced hypertensive rats: a dose-dependence study. Redox Rep 16, 208215.
14. Narasimhan, B, Ohlan, S, Ohlan, R, et al. (2009) Hansch analysis of veratric acid derivatives as antimicrobial agents. Eur J Med Chem 44, 689700.
15. Szwajgier, D, Pielecki, J, Targonski, Z, et al. (2005) Antioxidant activity of cinnamic and benzoic acid derivatives. Acta Sci Pol Technol Aliment 4, 129149.
16. Mattila, P & Kumpulainen, J (2002) Determination of free and total phenolic acids in plant-derived foods by HPLC with diode-array detection. J Agric Food Chem 50, 36603667.
17. Saravanakumar, M & Raja, B (2011) Veratric acid, a phenolic acid attenuates blood pressure and oxidative stress in l-NAME induced hypertensive rats. Eur J Pharmacol 671, 8794.
18. Saravanakumar, M & Raja, B (2012) Effect of veratric acid on the cardiovascular risk of l-NAME-induced hypertensive rats. J Cardiovasc Pharmacol 59, 553562.
19. Niehaus, WG Jr & Samuelsson, B (1968) Formation of malonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur J Biochem 6, 126130.
20. Jiang, ZY, Hunt, JV & Wolff, SP (1992) Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein. Anal Biochem 202, 384389.
21. Kakkar, P, Das, B & Viswanathan, PN (1984) A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys 21, 130132.
22. Sinha, AK (1972) Colorimetric assay of catalase. Anal Biochem 47, 389394.
23. Rotruck, JT, Pope, AL, Ganther, HE, et al. (1973) Selenium: biochemical role as a component of glutathione peroxidase. Science 179, 588590.
24. Ellman, GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82, 7077.
25. Roe, JH & Kuether, CA (1943) The determination of ascorbic acid in whole blood and urine through the 2,4-dinitrophenylhydrazine derivative of dehydroascorbic acid. J Biol Chem 147, 399407.
26. Baker, H, Frank, O, DeAngelis, B, et al. (1980) Plasma tocopherol in man at various times after ingesting free or acetylated tocopherol. Nutr Rep Int 21, 531536.
27. Fenning, A, Harrison, G, Rose'meyer, R, et al. (2005) L-Arginine attenuates cardiovascular impairment in DOCA-salt hypertensive rats. Am J Physiol Heart Circ Physiol 289, H1408H1416.
28. Rajasekaran, D, Manoharan, S, Silvan, S, et al. (2012) Proapoptotic, anti-cell proliferative, anti-inflammatory and anti-angiogenic potential of carnosic acid during 7,12 dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis. Afr J Tradit Complement Altern Med 10, 102112.
29. Katsumi, H, Nishikawa, M & Hashida, M (2007) Development of nitric oxide donors for the treatment of cardiovascular diseases. Cardiovasc Hematol Agents Med Chem 5, 204208.
30. Boe, AE, Eren, M, Murphy, SB, et al. (2013) Plasminogen activator inhibitor-1 antagonist TM5441 attenuates Nω-nitro-L-arginine methyl ester-induced hypertension and vascular senescence. Circulation 128, 23182324.
31. Yang, HY, Yang, SC, Chen, ST, et al. (2008) Soy protein hydrolysate ameliorates cardiovascular remodeling in rats with l-NAME-induced hypertension. J Nutr Biochem 19, 833839.
32. Ulker, S, McKeown, PP & Bayraktutan, U (2003) Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activities. Hypertension 41, 534539.
33. Ndisang, JF & Chibbar, R (2014) Heme oxygenase improves renal function by potentiating podocyte-associated proteins in Nω-nitro-l-arginine-methyl ester (l-NAME)-induced hypertension. Am J Hypertens 28, 930942.
34. Paulis, L, Zicha, J, Kunes, J, et al. (2008) Regression of l-NAME-induced hypertension: the role of nitric oxide and endothelium-derived constricting factor. Hypertens Res 31, 793803.
35. Dikalov, SI & Ungvari, Z (2013) Role of mitochondrial oxidative stress in hypertension. Am J Physiol Heart Circ Physiol 305, H1417H1427.
36. Rodrigo, R, Libuy, M, Feliú, F, et al. (2013) Oxidative stress-related biomarkers in essential hypertension and ischemia-reperfusion myocardial damage. Dis Markers 35, 773790.
37. Senthil, S, Veerappan, RM, Ramakrishna Rao, M, et al. (2004) Oxidative stress and antioxidants in patients with cardiogenic shock complicating acute myocardial infarction. Clin Chim Acta 348, 131137.
38. Seifi, B, Kadkhodaee, M, Karimian, SM, et al. (2010) Evaluation of renal oxidative stress in the development of DOCA-salt induced hypertension and its renal damage. Clin Exp Hypertens 32, 9097.
39. Karthikeyan, J & Rani, P (2003) Enzymatic and non-enzymatic antioxidants in selected Piper species. Indian J Exp Biol 41, 135140.
40. Abidi, P, Afaq, F, Arif, JM, et al. (1999) Chrysotile-mediated imbalance in the glutathione redox system in the development of pulmonary injury. Toxicol Lett 106, 3139.
41. Newaz, MA & Nawal, NN (1999) Effect of gamma-tocotrienol on blood pressure, lipid peroxidation and total antioxidant status in spontaneously hypertensive rats (SHR). Clin Exp Hypertens 21, 12971313.
42. Hiremath, P, Bauer, M, Aguirre, AD, et al. (2014) Identifying early changes in myocardial microstructure in hypertensive heart disease. PLOS ONE 9, e97424.
43. Chatziantoniou, C & Dussaule, JC (2005) Insights into the mechanisms of renal fibrosis: is it possible to achieve regression? Am J Physiol Renal Physiol 289, F227F234.
44. Olzinski, AR, McCafferty, TA, Zhao, SQ, et al. (2005) Hypertensive target organ damage is attenuated by a p38 MAPK inhibitor: role of systemic blood pressure and endothelial protection. Cardiovasc Res 66, 170178.
45. de Gasparo, M, Hess, P, Nuesslein-Hildesheim, B, et al. (2000) Combination of non-hypotensive doses of valsartan and enalapril improves survival of spontaneously hypertensive rats with endothelial dysfunction. J Renin Angiotensin Aldosterone Syst 1, 151158.
46. Mattson, DL, Kunert, MP, Roman, RJ, et al. (2005) Substitution of chromosome 1 ameliorates l-NAME hypertension and renal disease in the fawn-hooded hypertensive rat. Am J Physiol Renal Physiol 288, F1015F1022.
47. Mulvany, MJ, Baumbach, GL, Aalkjaer, C, et al. (1996) Vascular remodeling. Hypertension 28, 505506.
48. Nadruz, W (2015) Myocardial remodeling in hypertension. J Hum Hypertens 29, 16.
49. Díez, J, Querejeta, R, López, B, et al. (2002) Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 105, 25122517.
50. Manabe, I, Shindo, T & Nagai, R (2002) Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy. Circ Res 91, 11031113.
51. Mapanga, RF, Rajamani, U, Dlamini, N, et al. (2002) Oleanolic acid: a novel cardioprotective agent that blunts hyperglycemia-induced contractile dysfunction. PLoS ONE 7, e47322.
52. Versari, D, Daghini, E, Virdis, A, et al. (2009) Endothelium-dependent contractions and endothelial dysfunction in human hypertension. Br J Pharmacol 157, 527536.
53. Török, J (2008) Participation of nitric oxide in different models of experimental hypertension. Physiol Res 57, 813825.
54. Chen, B, Shi, L, Yu, X, et al. (2012) Differential effects of Rho-kinase inhibitor and angiotensin II type-1 receptor antagonist on the vascular function in hypertensive rats induced by chronic l-NAME treatment. Acta Pharm Sin B 2, 450458.
55. Kung, CF, Moreau, P, Takase, H, et al. (1995) l-NAME hypertension alters endothelial and smooth muscle function in rat aorta. Prevention by trandolapril and verapamil. Hypertension 26, 744751.
56. Fan, D, Takawale, A, Lee, J, et al. (2012) Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease. Fibrogenesis Tissue Repair 5, 15.
57. Ammarguellat, FZ, Gannon, PO, Amiri, F, et al. (2002) Fibrosis, matrix metalloproteinases, and inflammation in the heart of DOCA-salt hypertensive rats: role of ET(A) receptors. Hypertension 39, 679684.
58. Chen, H, Huang, XN, Stewart, AF, et al. (2004) Gene expression changes associated with fibronectin-induced cardiac myocyte hypertrophy. Physiol Genomics 18, 273283.



Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed